This week's report explores the pharmaceutical industry’s evolution toward resilient, scalable systems that prioritize ...

The mechanism underlying how seasonal allergies recur year after year with precise timing remains largely unknown. An international team led by Professor Rudolf Valenta has identified a specific type ...

A new University of Manchester and Edinburgh study published in the journal Brain, Behavior and Immunity has found that ...

The Indian Institute of Technology Roorkee (IIT Roorkee) has developed a next-generation antibody discovery platform with the ...

Sherry Gu, Executive Vice President and CTO at WuXi Biologics, explains the critical challenges of developing bispecific ...

1 The Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Kongens Lyngby, Denmark 2 Autralian Institute for Bioengineering and Nanotechnology, The University of ...

ACTON, Mass., Dec. 29, 2025 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay” or the “Company”) announced that it has completed commercial-scale production of both polyclonal and ...

This whitepaper examines how scalable magnetic separation technology can transform monoclonal antibody production by eliminating key downstream bottlenecks. The detailed economic model compares the ...

A multidisciplinary team of scientists led by The Wistar Institute, including Perelman School of Medicine at the University of Pennsylvania, AstraZeneca and Inovio Pharmaceuticals, published in Nature ...

The global biologics contract manufacturing (BCM) market is entering a period of rapid expansion, projected to grow from USD 35.2 billion in 2025 to USD 93.8 billion by 2035, representing a compound ...

Merck subsidiary MilliporeSigma acquired JSR Life Sciences, a contract development and manufacturing organization (CDMO) specializing in chromatography. JSR is a leader in bioprocessing solutions as ...